BioMarin Pharmaceutical | BMRN - 税前利润

股票价格
54.57
每天变化
0.36 0.66%
每月一次
-3.40%
每年
-12.98%
Q2 预测
52.04


金融业
股票价格
USD
资产
USD 7.59B
现金及等价物
USD 1.31B
销售成本
USD 161.56M
流动资产
USD 3.95B
流动负债
USD 759.03M
债务
USD 604.24M
EBIT
USD 198.39M
EBITDA
USD -24.17M
员工
3.04K
EPS每股收益
USD 0.46
股本和储备
USD 6.09B
销售毛利
USD 713.01M
债务利息支出
USD 2.78M
利息收入
USD 17.85M
贷款资金
USD 597.18M
市值
USD 10.28B
净收入
USD -46.57M
营业费用
USD 676.18M
营业利润
USD 198.39M
普通股股本
USD 192.3M
PE价格收益
19.24
税前利润
USD -26.32M
销售收入
USD 875M
销售和管理费用
USD 322.21M
股票
USD 1.3B
贸易债权人
USD 759.03M
应收帐款人
USD 908.21M


税前利润 更改 日
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Gilead Sciences USD 2.08B 1.56B 2025-12
Incyte USD 389.94M 92.37M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
Moderna USD -187M 631M 2025-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 6.23B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09